Extracellular legumain undergoes autoactivation in the acidic tumor microenvironment and participates in the remodeling of the ECM, either by directly hydrolyzing matrix components like fibronectin or by promoting the maturation of MMPs. The gene discussed is LGMN; the disease is neoplasm.